Compound heterozygous recessive thalassemia intermedia unusual presentation: a case report

  • Dr Rugmini Kamalammal Adichunchanagiri Institute of Medical Sciences, B G Nagara, Nagamangala Taluk, Mandya District, Karnataka, India
  • Dr Divya Narayanan Kutty Adichunchanagiri Institute of Medical Sciences, B G Nagara, Nagamangala Taluk, Mandya District, Karnataka, India
Keywords: Thalassemia intermedia, Alloimmunization, Compound heterozygousity

Abstract

About 3% of the world’s population carry β-Thalassemia genes. More than 200 mutations have been described, majority are point mutations and also some rare cases of gene deletion (17 deletions) have been reported. Those with Compound heterozygous inheritance present with two different mild β-thalassemia alleles and borderline RBC indices. We report a pre-adolescent girl with β-thalassemia intermedia who became transfusion dependent and developed alloimmunization.

This case is presented to highlight the fact that compound heterozygousity is a possible entity in a non-consanginous parentage and may present with subtle clinical features and minimal laboratory evidence and those children who start receiving transfusion later in their life are more prone for alloimmunization.

Downloads

Download data is not yet available.

References

1. Borgna-Pignatti C, Galanello R. Thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis. In: Greer JP, Rodgers GM, Paraskevas F, Foerster J, Lukens JN, Glader B, editors. Wintrobe's Clinical Hematology. 13th ed. Philadelphia: Lippincott Williams and Wilkins; 2014. p. 862-913. [PubMed]

2. Sarnaik AS. Thalassemia and Related Hemoglobinopathies. Indian J Pediatr. 2005; 72(4):319-24. [PubMed]

3. Christopher AF, Kumari A, Chaudhary S, Hora S, Ali Z, Agrawal SC. Unique pattern of mutations in β-thalassemia patients in Western Uttar Pradesh. Indian J Hum Genet. 2013 Apr;19(2):207-12. doi: 10.4103/0971-6866.116119. [PubMed]

4. Grow et al. Beta thalassemia in India: current status and the challenges ahead. Int J Pharm Sci. 2014;6(4):28-33. [PubMed]

5. Musallam KM, Taher AT, Rachmilewitz EA. β-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012 Jul;2(7):a013482. doi: 10.1101/cshperspect.a013482. [PubMed]

6. Sadeghian MH, Keramati MR, Badiei Z, et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian Journal of Transfusion Science. 2009;3(2):95-98.

7. Cappellini MD, Cohen A, Eleftheriou A, et al. Guidelines for the Clinical Management of Thalassaemia. 2nd Revised ed. Nicosia (CY): Thalassaemia International Federation; 2008.

8. Chaudhari CN. Red Cell Alloantibodies in Multiple Transfused Thalassaemia Patients. Med J Armed Forces India. 2011 Jan;67(1):34-7. doi: 10.1016/S0377-1237(11)80008-0. Epub 2011 Jul 21. [PubMed]

9. Morris CR, Vichinsky EP. Pulmonary hypertension in thalassemia. Ann N Y Acad Sci. 2010 Aug;1202:205-13. doi: 10.1111/j.1749-6632.2010.05580.x. [PubMed
Compound heterozygous recessive thalassemia intermedia unusual presentation: a case report
CITATION
DOI: 10.17511/ijpr.2016.i11.04
Published: 2016-11-30
How to Cite
Dr Rugmini Kamalammal, & Dr Divya Narayanan Kutty. (2016). Compound heterozygous recessive thalassemia intermedia unusual presentation: a case report. Pediatric Review: International Journal of Pediatric Research, 3(11), 798-801. https://doi.org/10.17511/ijpr.2016.i11.04
Section
Case Report